Item 8.01 Other Events.

On July 29, 2022, Adamis Pharmaceuticals Corporation (the "Company") issued a press release regarding the recommendations of Institutional Shareholder Services Inc., a leading independent proxy advisory firm, concerning certain of the proposals to be submitted to the Company's stockholders for consideration at the Company's annual meeting of stockholders scheduled to be held on August 12, 2022.

A copy of the Company's press release is filed with this Report as Exhibit 99.1.

© Edgar Online, source Glimpses